Latvia - Lipid Modifying Medicine Use

Since 2014, Latvia Lipid Modifying Medicine Use rose 7.4% year on year. With 80.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 23 comparing other countries in Lipid Modifying Medicine Use. Latvia is overtaken by Austria, which was ranked number 22 with 89.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by South Korea at 72.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark topped the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a growth of 3.5% compared to 2018. United Kingdom, Belgium and Norway respectively ranked number 2, 3 and 4 in this ranking. Lithuania recorded the best 5 years average growth at +15% per year, while Slovakia recorded the worst performance at -7% per year.

Loading...

Date Units (Defined Daily Dosage) Per Thousand Persons Per Day
2019 80.30
2018 77.60
2017 77.70
2016 67.80
2015 62.50
Download all data from 2012 to 2019

How does Latvia rank in Lipid Modifying Medicine Use?

# 28 Countries Units (Defined Daily Dosage) Per Thousand Persons Per Day Last YoY 5‑years CAGR
1 #1
Denmark
160 2019 +3.5 % +3.8 % View data
2 #2
United Kingdom
153 2019 +1.7 % +2.3 % View data
22 #22
Austria
90 2019 +2.4 % +4.3 % View data
23 #23
Latvia
80 2019 +3.5 % +7.4 % View data
24 #24
South Korea
73 2019 +3.7 % +7.0 % View data
Compare all 28 countries

Go Top